Delivery Order SPE2DR25D1050-SPE2DR26FZ4QA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,338.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular treatment. This firm fixed-price, non-set-aside delivery order was issued on November 26, 2025, with an ultimate completion date of November 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $22,429.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be supplied to the place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $24,163.14 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Repatha 140 mg/mL SureClick medication. This non-set-aside, firm fixed-price contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters,...
- The Defense Logistics Agency awarded a $31,632.15 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. This competitively awarded, firm fixed-price delivery order was established on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract involves no set-aside designation, reflecting AmerisourceBergen's ability to compete in open federal procurement. Performance will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.92 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-competitive delivery order represents a firm fixed-price purchase of specialty pharmaceutical products under the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $22,291.49 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,023.62 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication. This firm fixed price, competitively awarded contract was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $21,065.27 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a prescription pharmaceutical product used primarily for cholesterol management. This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by November 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,733.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This non-set-aside, firm fixed-price contract was competitively awarded on November 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $36,703.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 19, 2025. This non-set-aside competitive award was issued on September 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in...
- SPE2DR25D1050Indefinite Delivery Contract
- SPE2DR25D1050-SPE2DR26FZ4QADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,547.13 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a specialty pharmaceutical product. This non-competitive delivery order was issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. Repatha is a specialty cardiovascular medication used for cholesterol management, reflecting the company's role in supplying both brand-name and generic medications across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. The modest order value for this delivery order is consistent with AmerisourceBergen's contract portfolio, which ranges from small transactions to substantial orders exceeding $45,000, demonstrating the company's versatility in fulfilling diverse federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/3/25 |